Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Impact Of Bone Marrow Involvement On Outcome Of Young Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL) Treated In The Phase III Randomized Trial (DLCL04) With Rituximab Dose-Dense Chemotherapy Followed By Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Or Standard Rituximab Dose Dense Chemotherapy: A Study of The Fondazione Italiana Linfomi (FIL)

Blood (2013) 122 (21): 4340.

https://doi.org/10.1182/blood.V122.21.4340.4340

Published: 2013

Journal Articles

The PI3K-δ Inhibitor TGR-1202 In Combination With Brentuximab Vedotin (SGN-35) Synergistically Induces G2/M Phase Arrest and Cell Death Via Inhibition Of Tubulin Polymerization In Hodgkin Lymphoma Cell Lines

Silvia L Locatelli, PhD, Silvia Tartari, PhD, Luca Rubino, PhD, Ercole Brusamolino, MD, Luca Castagna, MD, Peter Sportelli, Armando Santoro, MD, Carmelo Carlo-Stella, MD

Blood (2013) 122 (21): 1835.

https://doi.org/10.1182/blood.V122.21.1835.1835

Published: 2013

Journal Articles

The PI3K/ERK Dual Inhibitor AEZS-136 Induces ROS-Dependent Necroptotic Cell Death and Exerts Potent Antitumor Effects In NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts

Silvia L Locatelli, PhD, Giuliano G Stirparo, Silvia Tartari, PhD, Elena Saba, PhD, Luca Rubino, PhD, Ercole Brusamolino, MD, Luca Castagna, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD

Blood (2013) 122 (21): 3067.

https://doi.org/10.1182/blood.V122.21.3067.3067

Published: 2013

Journal Articles

Role of Positron Emission Tomography (PET/CT) in Primary Mediastinal Large B Cell Lymphoma (PMLBCL): Preliminary Results of an International Phase II Trial (IELSG-26 Study) Conducted On Behalf of the International Extranodal Lymphoma Study Group (IELSG), the Fondazione Italiana Linfomi (FIL) and the UK NCRI Lymphoma Group

Blood (2012) 120 (21): 1566.

https://doi.org/10.1182/blood.V120.21.1566.1566

Published: 2012

Journal Articles

Mobilization of Hematopoietic Stem Cells by a Bendamustine-Containing Regimen in Hodgkin's Lymphoma

Antonella Anastasia, MD, Alessandro Pulsoni, Alessandro Re, MD, Francesco Merli, MD, Carmelo Carlo-Stella, MD, Cristina Gabutti, Luca Castagna, MD, Giorgia Annechini, Anna Marina Liberati, MD, Ercole Brusamolino, MD, Armando Santoro, MD

Blood (2012) 120 (21): 1914.

https://doi.org/10.1182/blood.V120.21.1914.1914

Published: 2012

Journal Articles

Rituximab Dose-Dense Chemotherapy Followed by Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Significantly Reduces the Risk of Progression Compared to Standard Rituximab Dose-Dense Chemotherapy As First Line Treatment in Young Patients with High-Risk (aa-IPI 2–3) Diffuse Large B-Cell Lymphoma (DLBCL): Final Results of Phase III Randomized Trial DLCL04 of the Fondazione Italiana Linfomi (FIL)

Blood (2012) 120 (21): 688.

https://doi.org/10.1182/blood.V120.21.688.688

Published: 2012

Journal Articles

Bendamustine for Relapsed/Refractory Classical Hodgkin Lymphoma After High Dose Chemotherapy and or Allogeneic Transplant: A Study of Fondazione Italiana Linfomi (FIL)

Antonella Anastasia, MD, Carmelo Carlo-Stella, MD, Paolo Corradini, MD, Flavia Salvi, Chiara Rusconi, Alessandro Pulsoni, Stefan Hohaus, MD, Patrizia Pregno, Simonetta Viviani, MD, Ercole Brusamolino, MD, Stefano Luminari, Laura Giordano, MD, Armando Santoro, MD

Blood (2012) 120 (21): 3652.

https://doi.org/10.1182/blood.V120.21.3652.3652

Published: 2012

Journal Articles

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

Marc PE André, MD, Oumedaly Reman, MD, Massimo Federico, MD, Théodore Girinski, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, PhD, Aspasia Stamatoulas, MD, Catherine Fortpied, Msc, Michel Meignan, MD, PhD, Annibale Versari, MD, Martin Hutchings, MD, John Raemaekers, MD

Blood (2012) 120 (21): 549.

https://doi.org/10.1182/blood.V120.21.549.549

Published: 2012

Journal Articles

IHP Interpretation Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hodgkin Lymphoma Patients without Bulky Disease

Blood (2010) 116 (21): 3890.

https://doi.org/10.1182/blood.V116.21.3890.3890

Published: 2010

Journal Articles

Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers

Blood (2010) 116 (21): 966.

https://doi.org/10.1182/blood.V116.21.966.966

Published: 2010

Journal Articles

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.

Blood (2009) 114 (22): 1713.

https://doi.org/10.1182/blood.V114.22.1713.1713

Published: 2009

Journal Articles

First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/II Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).

Marc PE André, MD, Oumédaly Reman, MD, Massimo Fédérico, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Théodore Girinski, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, Aspasia Stamatoullas, MD, Liliana Baila, MD, MSc, Catherine Fortpied, MSc, Michel Meignan, MD, John M. Raemaekers, MD, PhD

Blood (2009) 114 (22): 97.

https://doi.org/10.1182/blood.V114.22.97.97

Published: 2009

Journal Articles

Chromosomal Abnormalities and TET2 Involvement in Therapy-Related Myelodysplastic Syndromes (t-MDS) and Acute Myeloid Leukemias (t-AML).

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Cesare Astori, Paola Maria Cavigliano, Patrizia Zappasodi, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Celeste Calvello, Marilena Caresana, Ercole Brusamolino, Carlo Castagnola, Mario Lazzarino

Blood (2009) 114 (22): 2600.

https://doi.org/10.1182/blood.V114.22.2600.2600

Published: 2009

Journal Articles

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Maurizio Martelli, MD, Vittorio Stefoni, MD, Giuseppina Cabras, MD, Sergio Cortellazzo, MD, Ercole Brusamolino, MD, Alessandro Levis, MD, Barbara Botto, MD, Antonio De Vivo, MD, Fiammetta Natalino, MD, Finolezzi Erica, MD, Robert Foa, MD, Pier Luigi Zinzani, MD

Blood (2006) 108 (11): 4697.

https://doi.org/10.1182/blood.V108.11.4697.4697

Published: 2006

Journal Articles

Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim.

Maurizio Bonfichi, MD, Ercole Brusamolino, MD, Carmela Marseglia, BS, Chiara Rusconi, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 4245.

https://doi.org/10.1182/blood.V106.11.4245.4245

Published: 2005

Journal Articles

Unexpectedly High Incidence of Interstitial Pneumonia in Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 Supported with Pegfilgrastim.

Ercole Brusamolino, MD, Chiara Rusconi, MD, Luigi Montalbetti, MD, Livio Gargantini, MD, Graziella Pinotti, MD, Lilj Uziel, MD, Sergio Fava, MD, Luigi Rigacci, MD, Guido Pagnucco, MD, Guido Frigerio, MD, Mario Fiumano, MD, Luciano Banfi, MD, Francesco Rodeghiero, MD, Giovanni Ucci, MD, Alberto De Paoli, MD, Giuseppe Attardo Parrinello, MD, Enrica Morra, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 3330.

https://doi.org/10.1182/blood.V106.11.3330.3330

Published: 2005

Journal Articles

Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine.

Paolo Bernasconi, MD, Marco Paulli, MD, Ester Orlandi, MD, Vittorio Perfetti, MD, Ilaria Giardini, MD, Silvia Zibellini, MD, Laura Vanelli, MD, Annamaria Tenore, MD, Marina Boni, MD, Paola Maria Cavigliano, MD, Alessandra Algarotti, MD, Ercole Brusamolino, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 4973.

https://doi.org/10.1182/blood.V106.11.4973.4973

Published: 2005

Journal Articles

HCV Infection in Nongastric Marginal Zone B-Cell Lymphoma of MALT.

Blood (2005) 106 (11): 987.

https://doi.org/10.1182/blood.V106.11.987.987

Published: 2005

Journal Articles

Clinical Features and Outcome of 147 Patients with Diffuse Large B-Cell Lymphoma and Hepatitis C Virus Infection.

Carlo Visco, Luca Arcaini, Michele Merli, Annalisa Andreoli, Sara Burcheri, Achille Ambrosetti, Ercole Brusamolino, Mario Lazzarino, Giovanni Pizzolo, Francesco Rodeghiero

Blood (2005) 106 (11): 1921.

https://doi.org/10.1182/blood.V106.11.1921.1921

Published: 2005

Journal Articles

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

Andrea Gallamini, Caterina Stelitano, Roberta Calvi, Monica Bellei, Daniele Mattei, Umberto Vitolo, Fortunato Morabito, Maurizio Martelli, Ercole Brusamolino, Emilio Iannitto, Francesco Zaja, Sergio Cortelazzo, Luigi Rigacci, Liliana Devizzi, Giuseppe Todeschini, Gino Santini, Maura Brugiatelli, Massimo Federico, for the Intergruppo Italiano Linfomi

Blood (2004) 103 (7): 2474–2479.

https://doi.org/10.1182/blood-2003-09-3080

Published: 2004

NARROW

The PI3K-δ Inhibitor TGR-1202 In Combination With Brentuximab Vedotin (SGN-35) Synergistically Induces G2/M Phase Arrest and Cell Death Via Inhibition Of Tubulin Polymerization In Hodgkin Lymphoma Cell Lines

The PI3K/ERK Dual Inhibitor AEZS-136 Induces ROS-Dependent Necroptotic Cell Death and Exerts Potent Antitumor Effects In NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts

Mobilization of Hematopoietic Stem Cells by a Bendamustine-Containing Regimen in Hodgkin's Lymphoma

Bendamustine for Relapsed/Refractory Classical Hodgkin Lymphoma After High Dose Chemotherapy and or Allogeneic Transplant: A Study of Fondazione Italiana Linfomi (FIL)

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

IHP Interpretation Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hodgkin Lymphoma Patients without Bulky Disease

Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.

Chromosomal Abnormalities and TET2 Involvement in Therapy-Related Myelodysplastic Syndromes (t-MDS) and Acute Myeloid Leukemias (t-AML).

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim.

Unexpectedly High Incidence of Interstitial Pneumonia in Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 Supported with Pegfilgrastim.

Evolution of a True B-Cell Chronic Lymphocytic Leukaemia (B-CLL) in a Diffuse Immunocytoma after Treatment with Fludarabine.

HCV Infection in Nongastric Marginal Zone B-Cell Lymphoma of MALT.

Clinical Features and Outcome of 147 Patients with Diffuse Large B-Cell Lymphoma and Hepatitis C Virus Infection.

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only